English
German
Spanish
Italian
Japanese
United statesPerform Targeted Prostate Biopsy with Organ-Based Tracking (OBT) Fusion® Technology
KOELIS Trinity® MRI fusion biopsy leverages proprietary Organ-Based Tracking Fusion® (OBT) software. OBT continuously tracks the position of the prostate (not the probe) in real time. KOELIS Trinity®’s 3D ultrasound with OBT recognizes patient movement and pressure caused by the ultrasound probe, and automatically adjusts to maintain fusion and accuracy of targeted biopsy. With OBT Fusion®, you can record each biopsy core location with millimetric accuracy.
How does it work?
Organ-Based tracking fusion
Why should you switch toOBT Fusion®?
Competitive Biopsy Systems Require Manual Image Realignment
Other imaging systems indirectly infer the location of the prostate by tracking the ultrasound probe with electromagnetic or mechanical sensors. These methods assume a fixed distance between the mobile prostate and ultrasound probe and do not account for changes in prostate shape. Even the slightest deformation of the prostate leads to incorrect image registration and needle targeting. As a result, users of competitive technologies must constantly manually re-align ultrasound and MRI images throughout the procedure.
Incredibly Accurate Targeted Prostate Biopsy as Precise as 2.5 mm1
In a prospective clinical study, KOELIS Trinity® was found to have a targeting accuracy of 2.5 mm1. Compared to cognitive targeting of MRI lesions, the KOELIS Trinity® achieved superior accuracy and cancer detection rates. Higher cancer detection rates inform your treatment recommendations and can reduce the number of unnecessary biopsies for your practice and patients.
Advanced Visualization For Enhanced Diagnostic Confidence
KOELIS Trinity® combines the strengths of different imaging modalities so physicians have access to a powerful, all-in-one diagnostic tool with advanced visualization and diagnostics capabilities. The information-rich fused image boasts a much more intelligent workflow leading to more accurate diagnoses, meaning better outcomes for patients and a lower cost of treatment.
References
1 Mean precision was 2.5 mm (95% confidence interval: 1.8 mm, 3.3 mm). Positive cores were closer to the center than were negative cores (dCC: 1.7 mm vs 3.1 mm, respectively; P = .025) – Precision Matters in MR Imaging-targeted Prostate Biopsies: Evidence from a Prospective Study of Cognitive and Elastic Fusion Registration Transrectal Biopsies
User Testimonials
“The fusion-biopsy technique with Koelis not only makes diagnosis more accurate and safer for the patient, it also helps me in the operation room to perform better nerve-sparing surgeries, which directly translates to a superior health-related quality of life for patients suffering from prostate cancer.”
“For prostate cancer, precise diagnostics are essential for individualized therapy planning. 3D mapping of the prostate in combination with MRI sequences and needle tracking is particularly helpful.”
“The Koelis Trinity offers a precise 3D protocol of the biopsied PIRADS-suspect regions of the prostate, which helps me, as a performer of brachytherapy and focal therapy, to plan my procedure and at the same time explain clearly to the patient what needs to be done.”
